IHE holdings
iShares U.S. Pharmaceutical ETF
Positions
59 stored of 59 reported, largest first by weight
| # | Holding | ISIN | CUSIP | Weight | Value (USD) | Type | Issuer type | Country | Currency |
|---|---|---|---|---|---|---|---|---|---|
| 1 | JOHNSON & JOHNSON | US4781601046 | 478160104 | 22.444% | $255.5M | Equity (common) | Corporate | United States | USD |
| 2 | ELI LILLY AND COMPANY ELI LILLY CO | US5324571083 | 532457108 | 22.245% | $253.2M | Equity (common) | Corporate | United States | USD |
| 3 | BlackRock Funds III: BlackRock Cash Funds: Institutional; SL Agency Shares BLACKROCK CASH FUNDS INSTITUTIONAL FUND SL AGENCY | US0669225197 | 066922519 | 6.242% | $71.1M | Short-term investment vehicles (cash funds) | Registered fund | United States | USD |
| 4 | MERCK & CO., INC. | US58933Y1055 | 58933Y105 | 4.548% | $51.8M | Equity (common) | Corporate | United States | USD |
| 5 | BRISTOL-MYERS SQUIBB COMPANY | US1101221083 | 110122108 | 4.368% | $49.7M | Equity (common) | Corporate | United States | USD |
| 6 | ROYALTY PHARMA PLC | GB00BMVP7Y09 | G7709Q104 | 4.335% | $49.3M | Equity (common) | Corporate | United Kingdom | USD |
| 7 | VIATRIS INC. | US92556V1061 | 92556V106 | 4.221% | $48.0M | Equity (common) | Corporate | United States | USD |
| 8 | PFIZER INC. | US7170811035 | 717081103 | 3.965% | $45.1M | Equity (common) | Corporate | United States | USD |
| 9 | ZOETIS INC. | US98978V1035 | 98978V103 | 3.726% | $42.4M | Equity (common) | Corporate | United States | USD |
| 10 | JAZZ PHARMACEUTICALS PUBLIC LIMITED COMPANY JAZZ PHARMACEUTICALS PLC | IE00B4Q5ZN47 | G50871105 | 3.451% | $39.3M | Equity (common) | Corporate | Ireland | USD |
| 11 | ELANCO ANIMAL HEALTH INCORPORATED | US28414H1032 | 28414H103 | 2.806% | $31.9M | Equity (common) | Corporate | United States | USD |
| 12 | AXSOME THERAPEUTICS, INC. | US05464T1043 | 05464T104 | 2.415% | $27.5M | Equity (common) | Corporate | United States | USD |
| 13 | CORCEPT THERAPEUTICS INCORPORATED | US2183521028 | 218352102 | 1.896% | $21.6M | Equity (common) | Corporate | United States | USD |
| 14 | LIGAND PHARMACEUTICALS INCORPORATED | US53220K5048 | 53220K504 | 1.446% | $16.5M | Equity (common) | Corporate | United States | USD |
| 15 | Definium Therapeutics Inc | CA24477V1058 | 24477V105 | 1.389% | $15.8M | Equity (common) | Corporate | Canada | USD |
| 16 | Liquidia Corp | US53635D2027 | 53635D202 | 1.279% | $14.6M | Equity (common) | Corporate | United States | USD |
| 17 | INDIVIOR PHARMACEUTICALS, INC. | US45579U1097 | 45579U109 | 1.142% | $13.0M | Equity (common) | Corporate | United States | USD |
| 18 | Crinetics Pharmaceuticals Inc | US22663K1079 | 22663K107 | 0.901% | $10.3M | Equity (common) | Corporate | United States | USD |
| 19 | ORGANON & CO. | US68622V1061 | 68622V106 | 0.812% | $9.2M | Equity (common) | Corporate | United States | USD |
| 20 | Edgewise Therapeutics Inc | US28036F1057 | 28036F105 | 0.699% | $8.0M | Equity (common) | Corporate | United States | USD |
| 21 | AMNEAL PHARMACEUTICALS, INC. | US03168L1052 | 03168L105 | 0.681% | $7.8M | Equity (common) | Corporate | United States | USD |
| 22 | Enliven Therapeutics Inc | US29337E1029 | 29337E102 | 0.631% | $7.2M | Equity (common) | Corporate | United States | USD |
| 23 | SUPERNUS PHARMACEUTICALS, INC. | US8684591089 | 868459108 | 0.617% | $7.0M | Equity (common) | Corporate | United States | USD |
| 24 | Tarsus Pharmaceuticals Inc | US87650L1035 | 87650L103 | 0.568% | $6.5M | Equity (common) | Corporate | United States | USD |
| 25 | Veradermics Inc | US9229671048 | 922967104 | 0.562% | $6.4M | Equity (common) | Corporate | United States | USD |
| 26 | Alumis Inc | US0223071020 | 022307102 | 0.548% | $6.2M | Equity (common) | Corporate | United States | USD |
| 27 | NEKTAR THERAPEUTICS | US6402683063 | 640268306 | 0.539% | $6.1M | Equity (common) | Corporate | United States | USD |
| 28 | PRESTIGE CONSUMER HEALTHCARE INC. | US74112D1019 | 74112D101 | 0.511% | $5.8M | Equity (common) | Corporate | United States | USD |
| 29 | Trevi Therapeutics Inc | US89532M1018 | 89532M101 | 0.502% | $5.7M | Equity (common) | Corporate | United States | USD |
| 30 | OCULAR THERAPEUTIX, INC. | US67576A1007 | 67576A100 | 0.393% | $4.5M | Equity (common) | Corporate | United States | USD |
| 31 | INNOVIVA, INC. | US45781M1018 | 45781M101 | 0.364% | $4.1M | Equity (common) | Corporate | United States | USD |
| 32 | Amylyx Pharmaceuticals Inc | US03237H1014 | 03237H101 | 0.346% | $3.9M | Equity (common) | Corporate | United States | USD |
| 33 | ANI PHARMACEUTICALS, INC. | US00182C1036 | 00182C103 | 0.345% | $3.9M | Equity (common) | Corporate | United States | USD |
| 34 | MBX Biosciences Inc | US55287L1017 | 55287L101 | 0.336% | $3.8M | Equity (common) | Corporate | United States | USD |
| 35 | HARMONY BIOSCIENCES HOLDINGS, INC. | US4131971040 | 413197104 | 0.332% | $3.8M | Equity (common) | Corporate | United States | USD |
| 36 | PERRIGO COMPANY PUBLIC LIMITED COMPANY PERRIGO CO PLC | IE00BGH1M568 | G97822103 | 0.328% | $3.7M | Equity (common) | Corporate | Ireland | USD |
| 37 | HARROW, INC. | US4158581094 | 415858109 | 0.322% | $3.7M | Equity (common) | Corporate | United States | USD |
| 38 | NUVATION BIO INC. | US67080N1019 | 67080N101 | 0.316% | $3.6M | Equity (common) | Corporate | United States | USD |
| 39 | XERIS BIOPHARMA HOLDINGS, INC. | US98422E1038 | 98422E103 | 0.312% | $3.6M | Equity (common) | Corporate | United States | USD |
| 40 | Rapport Therapeutics Inc | US75383L1026 | 75383L102 | 0.273% | $3.1M | Equity (common) | Corporate | United States | USD |
| 41 | Collegium Pharmaceutical, Inc. | US19459J1043 | 19459J104 | 0.268% | $3.0M | Equity (common) | Corporate | United States | USD |
| 42 | EYEPOINT, INC. | US30233G2093 | 30233G209 | 0.257% | $2.9M | Equity (common) | Corporate | United States | USD |
| 43 | AtaiBeckley Inc | US04650F1012 | 04650F101 | 0.234% | $2.7M | Equity (common) | Corporate | United States | USD |
| 44 | PACIRA BIOSCIENCES, INC. | US6951271005 | 695127100 | 0.228% | $2.6M | Equity (common) | Corporate | United States | USD |
| 45 | WAVE Life Sciences Ltd | SG9999014716 | Y95308105 | 0.201% | $2.3M | Equity (common) | Corporate | Singapore | USD |
| 46 | Maze Therapeutics Inc | US5787841007 | 578784100 | 0.192% | $2.2M | Equity (common) | Corporate | United States | USD |
| 47 | LB Pharmaceuticals Inc | US50180M1080 | 50180M108 | 0.180% | $2.1M | Equity (common) | Corporate | United States | USD |
| 48 | BIOAGE Labs Inc | US09077V1008 | 09077V100 | 0.179% | $2.0M | Equity (common) | Corporate | United States | USD |
| 49 | Septerna Inc | US81734D1046 | 81734D104 | 0.175% | $2.0M | Equity (common) | Corporate | United States | USD |
| 50 | AMPHASTAR PHARMACEUTICALS, INC. | US03209R1032 | 03209R103 | 0.157% | $1.8M | Equity (common) | Corporate | United States | USD |
| 51 | OMEROS CORPORATION | US6821431029 | 682143102 | 0.157% | $1.8M | Equity (common) | Corporate | United States | USD |
| 52 | PHIBRO ANIMAL HEALTH CORPORATION | US71742Q1067 | 71742Q106 | 0.151% | $1.7M | Equity (common) | Corporate | United States | USD |
| 53 | THERAVANCE BIOPHARMA, INC. | KYG8807B1068 | G8807B106 | 0.146% | $1.7M | Equity (common) | Corporate | Cayman Islands | USD |
| 54 | CORMEDIX INC. | US21900C3088 | 21900C308 | 0.131% | $1.5M | Equity (common) | Corporate | United States | USD |
| 55 | PHATHOM PHARMACEUTICALS, INC. | US71722W1071 | 71722W107 | 0.127% | $1.4M | Equity (common) | Corporate | United States | USD |
| 56 | Arvinas Inc | US04335A1051 | 04335A105 | 0.123% | $1.4M | Equity (common) | Corporate | United States | USD |
| 57 | Evolus Inc | US30052C1071 | 30052C107 | 0.105% | $1.2M | Equity (common) | Corporate | United States | USD |
| 58 | BlackRock Funds III: BlackRock Cash Funds: Treasury; SL Agency Shares BLACKROCK CASH FUNDS TREASURY | US0669224778 | 066922477 | 0.071% | $808K | Short-term investment vehicles (cash funds) | Registered fund | United States | USD |
| 59 | XAV HEALTH CARE SEP26 | Not reported | Not reported | 0.002% | $27K | Equity derivatives | Other | United States | USD |